Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 1 |
Hassani et al. | no | yes: 2 |
Forrest at al. (metacyclic) | no | yes: 2 |
Forrest at al. (procyclic) | no | yes: 2 |
Silverman et al. | no | yes: 1 |
Pissara et al. | yes | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 3 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0008537 | proteasome activator complex | 2 | 11 |
GO:0032991 | protein-containing complex | 1 | 11 |
Related structures:
AlphaFold database: E9B5V5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 4 | 6 | PF00082 | 0.457 |
CLV_PCSK_PC1ET2_1 | 4 | 6 | PF00082 | 0.446 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.453 |
DOC_CYCLIN_yCln2_LP_2 | 51 | 57 | PF00134 | 0.627 |
DOC_MAPK_MEF2A_6 | 100 | 109 | PF00069 | 0.518 |
DOC_MAPK_MEF2A_6 | 171 | 179 | PF00069 | 0.588 |
DOC_USP7_MATH_1 | 151 | 155 | PF00917 | 0.541 |
DOC_USP7_MATH_1 | 173 | 177 | PF00917 | 0.585 |
DOC_USP7_MATH_1 | 38 | 42 | PF00917 | 0.544 |
DOC_USP7_UBL2_3 | 158 | 162 | PF12436 | 0.520 |
LIG_14-3-3_CanoR_1 | 221 | 229 | PF00244 | 0.691 |
LIG_Actin_WH2_2 | 102 | 117 | PF00022 | 0.604 |
LIG_Clathr_ClatBox_1 | 189 | 193 | PF01394 | 0.466 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.629 |
LIG_FHA_2 | 13 | 19 | PF00498 | 0.509 |
LIG_PCNA_yPIPBox_3 | 110 | 123 | PF02747 | 0.549 |
LIG_PCNA_yPIPBox_3 | 72 | 82 | PF02747 | 0.426 |
LIG_SH2_STAP1 | 210 | 214 | PF00017 | 0.454 |
LIG_SH2_STAP1 | 55 | 59 | PF00017 | 0.612 |
LIG_SH2_STAT5 | 148 | 151 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 55 | 58 | PF00017 | 0.516 |
LIG_SUMO_SIM_anti_2 | 21 | 27 | PF11976 | 0.555 |
LIG_UBA3_1 | 116 | 123 | PF00899 | 0.515 |
LIG_WRC_WIRS_1 | 203 | 208 | PF05994 | 0.539 |
MOD_CK1_1 | 222 | 228 | PF00069 | 0.695 |
MOD_CK2_1 | 12 | 18 | PF00069 | 0.464 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.399 |
MOD_CK2_1 | 67 | 73 | PF00069 | 0.618 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.631 |
MOD_GlcNHglycan | 171 | 174 | PF01048 | 0.647 |
MOD_GlcNHglycan | 193 | 197 | PF01048 | 0.500 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.465 |
MOD_GSK3_1 | 169 | 176 | PF00069 | 0.560 |
MOD_GSK3_1 | 194 | 201 | PF00069 | 0.465 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.412 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.585 |
MOD_N-GLC_1 | 222 | 227 | PF02516 | 0.738 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.697 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.541 |
MOD_NEK2_2 | 84 | 89 | PF00069 | 0.604 |
MOD_PIKK_1 | 194 | 200 | PF00454 | 0.487 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.418 |
MOD_PKA_2 | 151 | 157 | PF00069 | 0.489 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.536 |
MOD_Plk_1 | 18 | 24 | PF00069 | 0.517 |
MOD_Plk_2-3 | 14 | 20 | PF00069 | 0.498 |
MOD_Plk_4 | 109 | 115 | PF00069 | 0.492 |
MOD_Plk_4 | 173 | 179 | PF00069 | 0.514 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.548 |
MOD_SUMO_for_1 | 99 | 102 | PF00179 | 0.531 |
MOD_SUMO_rev_2 | 118 | 125 | PF00179 | 0.572 |
MOD_SUMO_rev_2 | 154 | 160 | PF00179 | 0.505 |
MOD_SUMO_rev_2 | 164 | 170 | PF00179 | 0.728 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I3A8 | Leptomonas seymouri | 72% | 100% |
A0A0S4JD53 | Bodo saltans | 36% | 100% |
A0A1X0NKN6 | Trypanosomatidae | 45% | 92% |
A0A3Q8IHQ9 | Leishmania donovani | 95% | 100% |
A0A3R7MG26 | Trypanosoma rangeli | 49% | 99% |
A4HMA7 | Leishmania braziliensis | 85% | 100% |
A4IAX3 | Leishmania infantum | 95% | 100% |
D0A282 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9AEQ0 | Leishmania major | 94% | 100% |